Insulin : deficiency, excess and resistance in human disease /

Insulin: Deficiency, Excess and Resistance in Human Disease provides an overview of the role of insulin in the pathogenesis of prevalent non-communicable diseases such as obesity, type 2 diabetes, cardiovascular disease, and cancer, along with a comprehensive review of insulin replacement therapies...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Muut tekijät: Krentz, Andrew J.
Aineistotyyppi: E-kirja
Kieli:englanti
Julkaistu: [S.l.] : Academic Press, 2023.
Aiheet:
Linkit:ScienceDirect
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

MARC

LEADER 00000cam a2200000 a 4500
001 on1418749883
003 OCoLC
005 20260915095214.0
006 m o d
007 cr |n|||||||||
008 240124s2023 xx o 000 0 eng d
040 |a YDX  |b eng  |c YDX  |d OPELS  |d UKAHL  |d OCLCO  |d N$T  |d OCLCQ  |d OCLCL  |d SFB  |d OCLCF  |d OCLCO 
020 |a 9780323985697  |q (electronic bk.) 
020 |a 0323985696  |q (electronic bk.) 
020 |z 9780323917070 
020 |z 0323917070 
035 |a (OCoLC)1418749883 
050 4 |a RC661.I6 
082 0 4 |a 615.3/65  |2 23/eng/20240205  |1 https://id.oclc.org/worldcat/ddc/E3VJKpMTFGKGxfJRcydRJxXcgh 
245 0 0 |a Insulin :  |b deficiency, excess and resistance in human disease /  |c edited by Andrew J. Krentz. 
260 |a [S.l.] :  |b Academic Press,  |c 2023. 
300 |a 1 online resource 
588 0 |a Print version record. 
505 0 |a Front Cover -- Insulin -- Copyright Page -- Contents -- List of contributors -- Foreword -- Preface -- 1 Normal physiology: insulin secretion and insulin action -- 1 Insulin biosynthesis and release in health and disease -- Insulin biosynthesis -- The insulin gene-comparative physiology -- Transcriptional regulation of insulin gene expression -- Metabolic regulation of insulin gene expression -- Regulation of preproinsulin transcript stability -- Regulation of translation of the preproinsulin transcript -- Regulation of the processing of the preproinsulin peptide -- Insulin release -- Concluding remarks -- References -- 2 Classic metabolic actions of insulin in humans: from physiology to disease and novel pharmacotherapeutics -- Introduction -- Insulin structure and synthesis -- Physiological actions of action -- Insulin transport and the insulin receptor -- Cellular insulin signaling -- Metabolic actions of insulin in classic target tissues -- Carbohydrate metabolism -- Lipid metabolism -- Protein metabolism -- Insulin dose-response considerations -- Carbohydrate metabolism -- Regulation of the postabsorptive metabolic state -- Response to oral glucose ingestion or mixed meals -- Lipid metabolism -- Fasting state -- Postprandial state -- Nonclassic roles of adipocytes: implications for insulin action and cardiometabolic disease -- Brown adipose tissue -- Amino acid and protein metabolism -- Clinical states of acute metabolic decompensation associated with insulin deficiency -- Diabetic ketoacidosis -- Hyperglycemic hyperosmolar state -- References -- 3 Nonclassic effects of insulin: physiological actions on the vascular tissues and pathophysiological contributions to athe... -- Introduction -- Overview of insulin and cardiovascular disease -- Effects of insulin on the vascular tissues and atherogenesis. 
505 8 |a Congenital disorders of glycosylation -- Diagnosis -- Diagnostic evaluation -- Genetic testing -- Management -- Medical therapy -- 18F-DOPA PET -- Surgery -- Diazoxide unresponsive diffuse hyperinsulinism -- Outcomes -- Glycemic outcomes -- Neurologic outcomes -- Conclusion -- References -- 9 Hypoglycemic disorders in adults -- Clinical manifestations -- Causes of hypoglycemia -- Hypoglycemia in the setting of diabetes therapy -- Diagnostic evaluation -- Who to evaluate? -- Diagnostic approach -- The supervised fast -- Interpretation of data -- Postprandial evaluation -- Localization studies -- Management -- Insulinoma -- Medical management -- Diazoxide -- Somatostatin analogs -- Other medications -- Other therapies -- Postgastric bypass hypoglycemia -- NIPHS -- Recurrence, survival, and surveillance -- Conclusion -- References -- 2c Insulin resistance in human disease -- 10 Obesity and insulin resistance: pathophysiology guiding precision therapy -- Introduction -- Insulin resistance: substrates and genetics -- Effect of adiposity on hepatic and extrahepatic insulin action -- Insulin suppression of lipolysis -- Insulin suppression of glycogenolysis and gluconeogenesis -- Effects of nonglucose nutrients on insulin secretion and action in people with prediabetes -- Insulin secretion, action, glucose effectiveness and postprandial glucose metabolism in type 2 diabetes -- Splanchnic glucose uptake and splanchnic glucose production -- Nocturnal regulation of glucose homeostasis in type 2 diabetes -- Effects of cortisol and glucagon on nocturnal glucose production in type 2 diabetes -- Therapeutic approaches -- Summary and conclusions -- References -- 11 The cardiometabolic syndrome and vascular disease: pivotal role of insulin -- Introduction -- Pathophysiology of atherosclerosis -- Role of insulin resistance in atherosclerosis. 
505 8 |a Role of insulin resistance and hyperglycemia in microvascular disease -- Genetic and epigenetic associations with insulin resistance and cardiovascular disease -- Clinical features of cardiometabolic syndrome and insulin resistance -- Prevention of diabetes and ASCVD -- Medical therapies for primary prevention and treatment of metabolic syndrome components: a brief overview -- Treatment of type 2 diabetes mellitus -- Conclusions -- References -- 12 Insulin resistance, hyperinsulinemia, and cancer: pathogenic considerations and therapeutic opportunities -- Introduction -- Visceral adipose tissue, inflammation, and insulin resistance -- Insulin resistance, hyperinsulinemia and cancer: epidemiologic links -- Visceral obesity, metabolic syndrome, and cancer -- Insulin resistance, hyperinsulinemia, and cancer -- Insulin resistance, hyperinsulinemia, and cancer: mechanisms -- Systemic inflammation -- The insulin IGF-1 axis -- Insulin and IGF-1 -- Insulin, IGF-1, and the tumor microenvironment -- Sex steroids -- Insulin and the gut microbiome -- Therapeutic considerations -- Exogenous insulin -- Insulin and cancer prevention -- Diet, exercise, and intentional weight loss -- Pharmacologic therapies -- Hyperinsulinemia and cancer cachexia -- Summary -- Funding -- Conflict of interest -- References -- 13 Insulin and neurodegenerative diseases -- Introduction -- The brain is an insulin-sensitive organ -- Receptor expression in the brain -- Insulin production and transport across the blood-brain barrier -- Insulin and insulin-like signaling in the brain -- Control of cellular metabolism by insulin -- Abnormalities associated with dysregulated insulin/IGF-1 signaling -- AD brains show insulin and IGF1 resistance -- Sources of brain insulin resistance in neurodegeneration -- Diabetes interventions for the prevention or treatment of neurodegeneration -- Conclusions. 
520 |a Insulin: Deficiency, Excess and Resistance in Human Disease provides an overview of the role of insulin in the pathogenesis of prevalent non-communicable diseases such as obesity, type 2 diabetes, cardiovascular disease, and cancer, along with a comprehensive review of insulin replacement therapies and novel cardioprotective and. 
650 0 |a Insulin  |x Therapeutic use  |x Effectiveness. 
650 0 |a Insulin resistance. 
650 2 |a Insulin Resistance  |0 (DNLM)D007333 
650 6 |a Insulinorésistance.  |0 (CaQQLa)201-0103063 
650 7 |a Insulin resistance  |2 fast  |0 (OCoLC)fst00974526 
650 7 |a Insulin  |x Therapeutic use  |x Effectiveness  |2 fast  |0 (OCoLC)fst00974520 
700 1 |a Krentz, Andrew J. 
776 0 8 |i Print version:  |z 0323917070  |z 9780323917070  |w (OCoLC)1284289935 
776 0 8 |i Print version:  |t Insulin.  |d Amsterdam : Academic Press, 2023  |z 9780323917070  |w (OCoLC)1377217312 
856 4 0 |3 ScienceDirect  |u https://www.sciencedirect.com/science/book/9780323917070